Abstract 237: Association Between The HDL-sized And Circulating Plasma Proteomes

Background: Mass spectrometry (MS) profiling has identified over 250 proteins associated with HDL that are thought to underlie the diverse atheroprotective properties of HDL particles and thus may be important biomarkers of cardiovascular disease (CVD) risk. Likewise, recent studies have identified circulating plasma proteins as biomarkers of CVD risk factors and health outcomes. However, few studies have compared the HDL proteome with the circulating plasma proteome. Purpose: The purpose of this analysis was to examine the relationship between the abundance of individual proteins measured in whole plasma and the HDL-sized plasma fraction. Methods: We examined the HDL-sized and circulating plasma proteomes in 156 Black (30%) and White men and women (61%) from the HERITAGE Family Study. HDL was isolated from plasma via gel filtration chromatography and untargeted MS analysis was performed via nano-HPLC-MS/MS. The whole plasma proteome was measured using a modified aptamer (SOMAscan) assay. The correlations between protein abundances in HDL and whole plasma were examined for 101 HDL-associated proteins present in at least 40% of the sample. Results: The abundance of 56 proteins in HDL-sized and whole plasma were significantly (5% FDR) correlated with the strongest correlation for Haptoglobin levels (r=0.83, p=1.1x10 -40 ) ( Table 1 ). The remaining significant correlations ranged from weak to moderate (r= 0.18-0.64) and were found among a mix of frequently and occasionally observed HDL proteins. Discussion: We found that protein abundance measured in HDL-sized and whole plasma were moderately to strongly correlated for several proteins, whereas 45% of protein levels showed no association between HDL-sized and whole plasma fractions. Given the inherit differences in measurement techniques and sources of proteins, it appears that the plasma HDL-sized proteome is mostly distinct from the circulating whole plasma proteome as measured by the SOMAscan assay.